Phosphodiesterase inhibitors and cerebral vasospasm
- PMID: 168844
- DOI: 10.1001/archneur.1975.00490500089013
Phosphodiesterase inhibitors and cerebral vasospasm
Abstract
Experimental cerebral vasospasm was studied in cat and monkey models. In the cat, the basilar artery was exposed by a transclival approach and spasm induced by the application of blood to the vessel. In the monkey, spasm was produced by injecting blood into the subarachnoid space. Vessel size was determined in the cat by direct observation and, in the monkey, by cerebral angiography. Several agents known to alter the synthsis and degradation of cyclic adenosine monophosphate (AMP) were used to modity the vasospasm produced. Isoproterenol (Norisodrine) and aminophyline were effective in reversing cerebral vasospasm when applied topically and when administered parenterally. It is suggested that manipulation of the cyclic AMP pathways may be an effective method of controlling cerebral vasospasm.
Similar articles
-
Phosphodiesterase inhibitors and cerebral vasospasm.Trans Am Neurol Assoc. 1974;99:137-40. Trans Am Neurol Assoc. 1974. PMID: 4377047 No abstract available.
-
Experimental cerebral vasospasm and cyclic adenosine monophosphate (c-AMP).Invest Radiol. 1975 May-Jun;10(3):239-43. doi: 10.1097/00004424-197505000-00008. Invest Radiol. 1975. PMID: 166052
-
Treatment of cerebral vasospasm by control of cyclic adenosine monophosphate.Surg Neurol. 1976 Oct;6(4):223-6. Surg Neurol. 1976. PMID: 184555
-
[Current management of cerebral vasospasm (author's transl)].No Shinkei Geka. 1978 Mar;6(3):229-34. No Shinkei Geka. 1978. PMID: 347323 Review. Japanese. No abstract available.
-
Physiological considerations important for the management of vasospasm.Surg Neurol. 1977 May;7(5):259-67. Surg Neurol. 1977. PMID: 324008 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous